Weifa
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Weifa is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragerø Municipality. Weifa is one of the world’s largest producers of Metformin hydrochloride and a leading producer of alkaloid opiates. Production facilities follow GMP standards.
Weifa is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragerø Municipality. Weifa is one of the world’s largest producers of Metformin hydrochloride and a leading producer of alkaloid opiates. Production facilities follow GMP standards. ==History== Weifa was founded by pharmacist Olaf Weider in 19401. ==Therapeutic areas== Weifa focuses on three therapeutic areas: Pain management Diabetes management Food supplements ==Products== bra!: Evening primrose oil. Bronkyl: Expectorant effervescent tablet. Dexyl: Nasal spray. Fanalgin: Pain reliever and fever reducer with an addition of caffeine. Ferromax: Iron supplement. Fluormax: Fluorine supplements. Ibux: A brand name for ibuprofen. Ibux Gel: A gel version of Ibux. Nazamér: Salt water spray. Nazaren: Salt water nasal spray. Paracet: A brand name for paracetamol. Paracetduo: Similar to Paracet with the addition of caffeine for increased pain relief. Proxan: Brand name for naproxen. Pyrivir: Relieves symptoms of cold sores. Samin: Symptom relief in patients with Osteoarthritis. Tigerbalsam: Heat rub. Tussin: Cough medicine. Weifa-C Nypeekstrakt: Vitamin C from rose hip extract. Weifa C-vitamin brusetabletter: Vitamin C effervescent tablets. Weifa Kalsium: Calcium supplements. ==Active ingredients== Codeine: Used in pain relievers and cough medicine. Metformin: Used in first-line treatment of diabetes mellitus type 2. Pholcodine: Used in cough medicine. ==Development== With a total of over 99 employees1, Weifa is today generating an annual turnover of approximately €40 million (35% of the turnover is achieved internationally). Weifa bases its development on 3 criteria: International expansion Expertise in pharmaceuticals and fine chemicals Partnership agreements ==Norway== Weifa has market leadership in pain management products for the Norwegian market, with a portfolio of branded products that includes established brand names such as the Ibux tablets, Paracet tablets and Paralgin Forte tablets. Branded products accounts for approximately 70% of net sales. ==Export== Weifa’s leading export markets are Germany and United Kingdom. Besides these two essential export markets, Weifa has a long-standing presence in all the main countries of the European Union, in Eastern Europe, in Africa, in North America, in South America and in Asia. ==References==
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377112122 under CC BY-SA 4.0; modifications have been made.